Physician profile
Mariya Boychev
NPI 1134886054
$325.36
in general payments reported to CMS, 2019-2025
11 companies · $295 in 2025
The $295 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $15.11 · 2024: $15.27 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $325.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $69.82 | 2023-2025 | Uplizna, Otezla, Repatha |
| Astellas Pharma US INC | $47.50 | 2025 | Izervay |
| Emd Serono, INC. | $45.18 | 2025 | |
| Sk Life Science, INC. | $29.73 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.81 | 2025 | Hyqvia |
| Ucb, INC. | $23.66 | 2025 | Rystiggo |
| Amneal Pharmaceuticals LLC | $22.36 | 2025 | Crexont |
| Cycle Pharmaceuticals INC | $18.26 | 2025 | Tascenso Odt, Bafiertam |
| Pfizer INC. | $15.27 | 2024 | |
| Abbvie INC. | $13.90 | 2025 | |
| Novartis Pharmaceuticals Corporation | $13.87 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mariya Boychev listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.